Oren Steen

4.0k total citations · 1 hit paper
18 papers, 340 citations indexed

About

Oren Steen is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Physiology. According to data from OpenAlex, Oren Steen has authored 18 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Oren Steen's work include Diabetes Treatment and Management (7 papers), Pharmacology and Obesity Treatment (5 papers) and Restraint-Related Deaths (2 papers). Oren Steen is often cited by papers focused on Diabetes Treatment and Management (7 papers), Pharmacology and Obesity Treatment (5 papers) and Restraint-Related Deaths (2 papers). Oren Steen collaborates with scholars based in Canada, Germany and Ireland. Oren Steen's co-authors include Ronald Goldenberg, Stein Opjordsmoen, Erlend Hem, Anna Unseld, Anita M. Hennige, Carel W. le Roux, Kathryn Jean Lucas, Philip M. Sherman, David Prescott and Johan D. Söderholm and has published in prestigious journals such as Infection and Immunity, Metabolism and Obesity.

In The Last Decade

Oren Steen

17 papers receiving 327 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

2024 112 citations Carel W. le Roux, Oren Steen et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oren Steen Canada	8	163	83	77	66	63	18	340
Zeynep Oşar Türkiye	9	120 0.7×	46 0.6×	63 0.8×	64 1.0×	54 0.9×	13	323
Giuseppina Guarino Italy	14	314 1.9×	47 0.6×	67 0.9×	40 0.6×	129 2.0×	55	596
Shohinee Sarma Canada	5	99 0.6×	60 0.7×	69 0.9×	146 2.2×	89 1.4×	22	396
Parminder Singh India	10	129 0.8×	41 0.5×	61 0.8×	51 0.8×	31 0.5×	36	305
Sophia C. Jansen Netherlands	11	138 0.8×	19 0.2×	49 0.6×	77 1.2×	18 0.3×	15	365
Ligeia Damaso United States	11	157 1.0×	34 0.4×	92 1.2×	101 1.5×	41 0.7×	12	394
Lizeth Cifuentes United States	12	204 1.3×	158 1.9×	107 1.4×	186 2.8×	109 1.7×	35	517
Jana Malinčíková Czechia	7	134 0.8×	16 0.2×	53 0.7×	83 1.3×	33 0.5×	12	339
Beverly G. Tchang United States	11	144 0.9×	102 1.2×	66 0.9×	175 2.7×	82 1.3×	28	392
Elham Kazemian Iran	14	153 0.9×	19 0.2×	94 1.2×	89 1.3×	28 0.4×	39	540

Countries citing papers authored by Oren Steen

Since Specialization

Citations

This map shows the geographic impact of Oren Steen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oren Steen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oren Steen more than expected).

Fields of papers citing papers by Oren Steen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oren Steen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oren Steen. The network helps show where Oren Steen may publish in the future.

Co-authorship network of co-authors of Oren Steen

This figure shows the co-authorship network connecting the top 25 collaborators of Oren Steen. A scholar is included among the top collaborators of Oren Steen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oren Steen. Oren Steen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bushnell, Donald M., Meryl Brod, Carl Roberts, et al.. (2025). Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight. Obesity. 33(7). 1249–1262. 2 indexed citations

Roux, Carel W. le, Oren Steen, Kathryn Jean Lucas, et al.. (2025). Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m ² in the phase 2 trial of survodutide, a glucagon/ GLP ‐1 receptor dual agonist. Diabetes Obesity and Metabolism. 27(4). 1773–1782. 1 indexed citations

Steen, Oren, et al.. (2024). A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity. Metabolism. 153. 155848–155848.

Roux, Carel W. le, et al.. (2024). Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. The Lancet Diabetes & Endocrinology. 12(3). 162–173. 112 indexed citations breakdown →

Pieber, Thomas R., Olubukola Ajala, Oren Steen, et al.. (2021). Immunogenicity of the novel glucagon analog dasiglucagon: Results of a dedicated immunogenicity trial in type 1 diabetes. Diabetes Technology & Therapeutics. 23(11). 773–776. 2 indexed citations

Bajaj, Harpreet S., et al.. (2020). Goal achievement of HbA1c and LDL‐ cholesterol in a randomized trial comparing colesevelam with ezetimibe: GOAL‐RCT. Diabetes Obesity and Metabolism. 22(10). 1722–1728. 7 indexed citations

Goldenberg, Ronald & Oren Steen. (2018). Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes. Canadian Journal of Diabetes. 43(2). 136–145. 55 indexed citations

Steen, Oren & Ronald Goldenberg. (2017). WITHDRAWN: The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes. Canadian Journal of Diabetes. 2 indexed citations

Steen, Oren & Ronald Goldenberg. (2017). The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes. Canadian Journal of Diabetes. 41(5). 517–523. 15 indexed citations

10.

Steen, Oren, et al.. (2016). Corrected Calcium Formula in Routine Clinical Use Does Not Accurately Reflect Ionized Calcium in Hospital Patients. 11(3). 14–21. 9 indexed citations

11.

Chan, Winnie, et al.. (2015). An Unusual Cause of Severe Immunosuppression. 10(3). 48–51. 1 indexed citations

12.

Steen, Oren & Ally P.H. Prebtani. (2015). Physical Activity Patterns Among Resident and Staff Physicians in Hamilton Teaching Hospitals. 10(1). 29–33. 4 indexed citations

13.

Steen, Oren & Ally P.H. Prebtani. (2015). Physical Activity Patterns Among Resident and Staff Physicians in Hamilton Teaching Hospitals. 10(1). 29–33. 1 indexed citations

14.

Chan, Winnie, et al.. (2015). An Unusual Cause of Severe Immunosuppression. 10(3). 48–51. 1 indexed citations

15.

Steen, Oren, et al.. (2014). An Unusual Case of a Composite Pheochromocytoma With Neuroblastoma. Journal of Endocrinology and Metabolism. 4. 39–46. 4 indexed citations

16.

Nazli, Aisha, Arthur Wang, Oren Steen, et al.. (2005). Enterocyte Cytoskeleton Changes Are Crucial for Enhanced Translocation of NonpathogenicEscherichia coliacross Metabolically Stressed Gut Epithelia. Infection and Immunity. 74(1). 192–201. 51 indexed citations

17.

Hem, Erlend, Oren Steen, & Stein Opjordsmoen. (2001). Thrombosis associated with physical restraints. Acta Psychiatrica Scandinavica. 103(1). 73–76. 53 indexed citations

18.

Hem, Erlend, Oren Steen, & Stein Opjordsmoen. (2001). Thrombosis associated with physical restraints. Acta Psychiatrica Scandinavica. 103(1). 73–76. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact